FELLOWS DAVID A 4
4 · Terns Pharmaceuticals, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
FELLOWS DAVID A
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-07-01+8,183→ 8,183 totalExercise: $6.85Exp: 2034-06-30→ Common Stock (8,183 underlying)
Footnotes (2)
- [F1]This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $35,000 for the third and fourth quarters of 2024.
- [F2]The option will vest as to 1/6th of the total shares subject thereto on each monthly anniversary of the date of grant, such that 100% of the shares subject to the option will be fully vested on January 1, 2025.